Table 4.
Antibacterial activity of compounds 11 (4-bromo-N-{5-[(4-chlorophenyl)methyl]-1,3,4-thiadiazol-2-yl}benzene-1-sulfonamide) and 13 (5′-(4-fluorobenzamido)-[2,3′-bithiophene]-4′-carboxylic acid) against selected archival strains.
| Species | Strain ID | Source | Activity | |
|---|---|---|---|---|
| Compound 11 | Compound 13 | |||
| Escherichia coli | ATCC 25922 | ATCC* | − | ± |
| Klebsiella pneumoniae | 181210171-2 | Clinic of the Bashkir State Medical University | ± | + |
| Pseudomonas aeruginosa | ATCC 27853 | ATCC | − | − |
| Staphylococcus aureus | ATCC USA 206 | Clinic of the Bashkir State Medical University | ++++ | ++++ |
| Candida albicans | 181210169-1 | ATCC | + | ± |
*ATCC, American Type Culture Collection.